Regional Distribution of Ventilation in Patients With Chronic Heart Failure
Launched by UNIVERSIDADE FEDERAL DE PERNAMBUCO · Feb 9, 2011
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed as CHF associated with cardiomegaly
- • Class II and III (NYHA)
- • Left ventricular minor 45% (method Teicholtz)
- • Inspiratory muscle weakness (PiMáxima \<70% predicted)
- • Duration of symptoms \> 1 year
- • Body mass index (BMI) \< 35kg/m2
- • Non-smokers or former smokers with a smoking history \< 10 pack-years
- Exclusion Criteria:
- • Patients with chronic heart failure who had unstable angina, myocardial infarction or heart surgery until three months before the survey
- • Orthopedic diseases or respiratory comorbidities such as asthma and COPD
About Universidade Federal De Pernambuco
Universidade Federal de Pernambuco (UFPE) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation across various disciplines, including health sciences. As a clinical trial sponsor, UFPE leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving healthcare outcomes. The university is dedicated to ethical research practices and collaborates with a diverse array of institutions and stakeholders to facilitate the development of new therapies and interventions, ultimately contributing to the enhancement of public health both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Recife, Pernambuco, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials